Dr. Isaias Irgau, CEO Kemal Erkan
FAQ's
Answer : According to Precedence Research, the global biotechnology instruments market size was reached at USD 44.81 billion in 2021 and is anticipated to surpass over USD 107.5 billion by 2030.
Answer : The global biotechnology instruments market is expected to drive growth at a CAGR of 10.2% from 2021 to 2030.
Answer : The global biotechnology instruments market is primarily driven by the rising usage in the development of vaccines, drugs, novel therapies, and diagnostic tests.
Answer : The major players operating in the biotechnology instruments market are Abbott, Agilent Technologies, Alcon, Inc., AngioDynamics, Becton, Dickinson, and Company, BioMerieux SA, Bio-Rad Laboratories, BioTek Instruments, Inc., Candela Medical, Cynosure, LLC, Danaher Corporation, Endress+Hauser, F. Hoffmann-La Roche Ltd., IIlumina Inc., IRIDEX, and Lumenis.
Answer : North America dominated the global biotechnology instruments market in 2020 and will lead in the forecast period 2021 to 2030.